Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.43 |
| ▸ | MYC | P01106 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.42 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25669658 | 0.88 | CA12 (0.50) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL166744 | 0.83 | CYP3A4 (0.48) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL38868 | 0.82 | CYP3A4 (0.52) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL38891 | 0.82 | HMGB1 (0.62) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL31026219 | 0.82 | CYP3A4 (0.52) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL24677705 | 0.80 | CYP3A4 (0.41) | CYP3A4ACHEMEN1KMT2ATDP1 | |
| SCHEMBL11785416 | 0.80 | HMGB1 (0.60) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL9353947 | 0.80 | CYP3A4 (0.67) | CYP3A4ACHEKDM4EMEN1KMT2A | |
| SCHEMBL1259082 | 0.79 | KDM4E (0.63) | KDM4EMEN1KMT2ATDP1CA1 | |
| SCHEMBL18311221 | 0.78 | CYP3A4 (0.48) | CYP3A4ACHEKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231515-B1 | PROCESS FOR PRODUCING CARBON | SUMITOMO CHEMICAL CO (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-8129411-B2 | Organic compounds | NOVARTIS AG (CH) | 2012-03-06 | — | — | US | disclosed |
| US-8129411-B2 | Organic compounds | NOVARTIS AG (CH) | 2012-03-06 | — | — | US | disclosed |
| EP-2420491-A1 | 3 , 5-substitued piperidine compounds as renin inhibitors | Novartis AG (CH) | 2012-02-22 | — | — | EP | disclosed |
| US-20100316555-A1 | PROCESS FOR PRODUCING CARBON | Sumitomt Chemical Company, Limited (JP) | 2010-12-16 | — | — | US | disclosed |
| CN-101910059-A | Process for producing carbon | SUMITOMO CHEMICAL CO | 2010-12-08 | — | — | CN | disclosed |
| EP-2231515-A2 | PROCESS FOR PRODUCING CARBON | Sumitomo Chemical Company, Limited (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20090192148-A1 | Organic Compounds | NOVARTIS AG (CH) | 2009-07-30 | — | — | US | disclosed |
| US-20090192148-A1 | Organic Compounds | NOVARTIS AG (CH) | 2009-07-30 | — | — | US | disclosed |
| WO-2009082026-A2 | PROCESS FOR PRODUCING CARBON | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192148-A1 | Organic Compounds | REN, ACE, AGTR1 | CYP3A4 416/4885ACHE 394/4885KDM4E 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.